Lv4
750 积分 2024-12-10 加入
Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology
14天前
已完结
Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy
14天前
已完结
Estimation Methods for Estimands Using the Treatment Policy Strategy; a Simulation Study Based on the PIONEER 1 Trial
14天前
已完结
A rank-based approach to improve the efficiency of inferential seamless phase 2/3 clinical trials with dose optimization
16天前
已完结
Group Sequential and Confirmatory Adaptive Designs in Clinical Trials
3个月前
已完结
Group Sequential and Adaptive Methods for Clinical Trials
3个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
3个月前
已完结
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
6个月前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
6个月前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
